Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Dec 10 2021 | EVUSHELD (formerly AZD7442) long-acting antibody combination authorized for emergency use in the US for pre-exposure prophylaxis (prevention) of COVID-19 Industry News Industry Read More Dec 8 2021 | Maximize Your HFSA Membership Practice News Membership Read More Dec 3 2021 | Heart Failure Awareness 365: Highlights From 2021 Patient News Heart Failure Awareness 365 Patient Resource Read More Nov 22 2021 | Bristol Myers Squibb Announces New PDUFA Date for Mavacamten Industry News In The News Industry Read More Nov 19 2021 | Medicare Coverage of Innovative Technology (MCIT) HFSA News Advocacy Read More Pagination First page « First Previous page ‹ Previous … Page 68 Page 69 Page 70 Page 71 Current page 72 Page 73 Page 74 Page 75 Page 76 … Next page Next › Last page Last »
Dec 10 2021 | EVUSHELD (formerly AZD7442) long-acting antibody combination authorized for emergency use in the US for pre-exposure prophylaxis (prevention) of COVID-19 Industry News Industry Read More
Dec 3 2021 | Heart Failure Awareness 365: Highlights From 2021 Patient News Heart Failure Awareness 365 Patient Resource Read More
Nov 22 2021 | Bristol Myers Squibb Announces New PDUFA Date for Mavacamten Industry News In The News Industry Read More
